Catherine Piveteau

1.4k total citations
25 papers, 496 citations indexed

About

Catherine Piveteau is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Catherine Piveteau has authored 25 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Catherine Piveteau's work include Tuberculosis Research and Epidemiology (7 papers), Biochemical and Molecular Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). Catherine Piveteau is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Biochemical and Molecular Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). Catherine Piveteau collaborates with scholars based in France, Belgium and Cameroon. Catherine Piveteau's co-authors include Benoît Déprez, Florence Leroux, Marion Flipo, Nicolas Willand, Priscille Brodin, Alain R. Baulard, Adrien Herlédan, Rebecca Deprez‐Poulain, Vincent Villeret and Baptiste Villemagne and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Catherine Piveteau

23 papers receiving 488 citations

Peers

Countries citing papers authored by Catherine Piveteau

Since Specialization

Citations

This map shows the geographic impact of Catherine Piveteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Piveteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Piveteau more than expected).

Fields of papers citing papers by Catherine Piveteau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Piveteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Piveteau. The network helps show where Catherine Piveteau may publish in the future.

Co-authorship network of co-authors of Catherine Piveteau

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Piveteau. A scholar is included among the top collaborators of Catherine Piveteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Piveteau. Catherine Piveteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ERAP2 inhibitor −incorporated nanofibers: Characterization and biological assessment 2026 ·International Journal of Pharmaceutics ·(unknown), (unknown), Adrien Herlédan, Catherine Piveteau, (unknown), Hermis Iatrou, (unknown)	0
2	Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Valentin Sencio, Jonathan Chatagnon, (unknown), Janelle M. Fine, Séverine Heumel, Cyril Robil, (unknown), Catherine Piveteau, Sandrine Belouzard, Priscille Brodin, François Trottein, Arnaud Machelart, Ruxandra Gref	0
3	Molecular mechanism of a triazole-containing inhibitor of Mycobacterium tuberculosis DNA gyrase 2024 ·iScience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Catherine Piveteau, (unknown), (unknown), Anne Marie Wehenkel, Francesca Gubellini, Ariel Méchaly, Pedro M. Alzari, Benoît Déprez, Alain R. Baulard, Alexandra Aubry, Nicolas Willand, S. Petrella	4
4	Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Valérie Landry, Pascal Roussel, Catherine Piveteau, Florence Leroux, Ruben C. Hartkoorn, Nicolas Willand	1
5	Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification 2023 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Catherine Piveteau, Florence Leroux, (unknown), Stéphanie Slupek, Rudy Antoine, (unknown), François‐Xavier Cantrelle, Xavier Hanoulle, Jana Korduláková, Benoît Déprez, Nicolas Willand, Alain R. Baulard, Marion Flipo	2
6	Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump 2023 ·European Journal of Medicinal Chemistry ·(unknown), Juan-Carlos Jiménez-Castellanos, (unknown), Elizabeth Pradel, (unknown), Catherine Piveteau, (unknown), (unknown), Florence Leroux, Benoît Déprez, Nicolas Willand, Ruben C. Hartkoorn, Marion Flipo	6
7	Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae 2023 ·EMBO Molecular Medicine ·(unknown), Juan-Carlos Jiménez-Castellanos, (unknown), Laurye Van Maele, (unknown), Elizabeth Pradel, (unknown), (unknown), Daphnée Soulard, Catherine Piveteau, (unknown), Julie Dumont, Florence Leroux, Benoît Déprez, Nicolas Willand, Klaas M. Pos, Achilleas S. Frangakis, Ruben C. Hartkoorn, Marion Flipo	12
8	Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xavier Hanoulle, Valérie Landry, Danai Moschidi, Lowiese Desmarets, Yves Rouillé, Julie Dumont, Adrien Herlédan, (unknown), Catherine Piveteau, (unknown), (unknown), François‐Xavier Cantrelle, Elian Dupré, Jean Dubuisson, Sandrine Belouzard, Florence Leroux, Benoît Déprez, Julie Charton	12
9	Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers’ Lactamization 2023 ·Pharmaceuticals ·(unknown), (unknown), Catherine Piveteau, Frédéric Capet, (unknown), Michel Marion, Marion Flipo, Benoît Déprez, Nicolas Willand, Baptiste Villemagne	1
10	Occurrence of bisphenols and contribution of edibles liquids conditioned in plastic packaging to the dietary exposure in Cameroon 2022 ·Scientific African ·(unknown), Catherine Piveteau, (unknown), (unknown), Benoît Déprez	3
11	Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Claire Hamela, (unknown), (unknown), (unknown), Rudy Antoine, Adrien Herlédan, Florence Leroux, Catherine Piveteau, (unknown), Marion Flipo, Benoît Déprez, Laurent Kremer, Nicolas Willand, Baptiste Villemagne, Ruben C. Hartkoorn	14
12	Identification of indole-based activators of insulin degrading enzyme 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xiaoan Wen, Valérie Landry, Adrien Herlédan, Florence Leroux, Damien Bosc, Julie Charton, (unknown), (unknown), Isabelle Duplan, Catherine Piveteau, Nathalie Hennuyer, Bart Staels, Benoît Déprez, Rebecca Deprez‐Poulain	7
13	High-Throughput Image-Based Aggresome Quantification 2020 ·SLAS DISCOVERY ·(unknown), Ludovic Chaput, (unknown), (unknown), Catherine Piveteau, Julie Dumont, (unknown), Benoît Déprez, Florence Leroux	7
14	Modulators of hERAP2 discovered by high-throughput screening 2020 ·European Journal of Medicinal Chemistry ·(unknown), Ronan Gealageas, (unknown), (unknown), (unknown), (unknown), Catherine Piveteau, (unknown), (unknown), (unknown), Julie Charton, (unknown), Damien Bosc, Florence Leroux, Peter Van Endert, Benoît Déprez, Rebecca Deprez‐Poulain	10
15	Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity 2020 ·ACS Infectious Diseases ·Baptiste Villemagne, Arnaud Machelart, (unknown), Marion Flipo, (unknown), Florence Leroux, Catherine Piveteau, Alexandre Wohlkönig, René Wintjens, Xue Li, Ruxandra Gref, Priscille Brodin, Benoît Déprez, Alain R. Baulard, Nicolas Willand	14
16	Drug Target Engagement Using Coupled Cellular Thermal Shift Assay—Acoustic Reverse-Phase Protein Array 2019 ·SLAS DISCOVERY ·Adrien Herlédan, (unknown), (unknown), Florence Leroux, (unknown), Catherine Piveteau, (unknown), Cyril Couturier, Benoît Déprez, Rebecca Deprez‐Poulain	9
17	Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 2017 ·Scientific Reports ·(unknown), Elisabetta Pancani, Samuel Jouny, Arnaud Machelart, Vincent Delorme, Giuseppina Salzano, Raffaella Iantomasi, Catherine Piveteau, Christophe J. Queval, Ok‐Ryul Song, Marion Flipo, Benoît Déprez, Jean‐Paul Saint‐André, J. Hureaux, Laleh Majlessi, Nicolas Willand, Alain R. Baulard, Priscille Brodin, Ruxandra Gref	67
18	Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance 2017 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Nathalie Hennuyer, Florence Leroux, Catherine Piveteau, (unknown), Sophie Lestavel, Emmanuelle Vallez, Emilie Dorchies, Isabelle Duplan, Emmanuel Sevin, Maxime Culot, Fabien Gosselet, (unknown), Adrien Herlédan, Bart Staels, Benoît Déprez, Anne Tailleux, Julie Charton	52
19	In vivo efficacy of microbiota-sensitive coatings for colon targeting: A promising tool for IBD therapy 2014 ·Journal of Controlled Release ·Y. Karrout, Laurent Dubuquoy, Catherine Piveteau, F. Siepmann, (unknown), Daniel Wils, Terence Beghyn, Christel Neut, Marie‐Pierre Flament, Laetitia Guérin‐Deremaux, L. Dubreuil, Benoît Déprez, Pierre Desreumaux, Juergen Siepmann	38
20	Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737 2014 ·SLAS DISCOVERY ·Anne‐Laure Mathieu, Olivier Spérandio, (unknown), (unknown), Adrien Herlédan, (unknown), Marie‐Laure Fogeron, Catherine Piveteau, (unknown), Benoît Déprez, Bruno O. Villoutreix, Nathalie Bonnefoy, Florence Leroux	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact